Sample Request

Global Drug Repositioning Market 2021 by Company, Regions, Type and Application, Forecast to 2026

SELECT LICENSE:

Published on 04/04/2021| Code: GINR42221| Category: Information Technology| Total Pages: 92

The Drug Repositioning market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Drug Repositioning size is estimated to be USD 30630 million in 2026 from USD 25680 million in 2020, with a change XX% between 2020 and 2021. The global Drug Repositioning market size is expected to grow at a CAGR of 4.5% for the next five years.

Market segmentation

Drug Repositioning market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Generic Drugs

Clinical Trial Failed Drugs

Market segment by Application, can be divided into

Cardiovascular Diseases

Mental Illness

Cancer

Others

Market segment by players, this report covers

Teva

Novartis

Mylan

Johnson & Johnson

Pfizer

Bausch Health

GSK

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Drug Repositioning product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Drug Repositioning, with revenue, gross margin and global market share of Drug Repositioning from 2019 to 2021.

Chapter 3, the Drug Repositioning competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Drug Repositioning market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Drug Repositioning research findings and conclusion, appendix and data source.

1 Market Overview

1.1 Product Overview and Scope of Drug Repositioning

1.2 Classification of Drug Repositioning by Type

1.2.1 Overview: Global Drug Repositioning Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Drug Repositioning Revenue Market Share by Type in 2020

1.2.3 Generic Drugs

1.2.4 Clinical Trial Failed Drugs

1.3 Global Drug Repositioning Market by Application

1.3.1 Overview: Global Drug Repositioning Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Cardiovascular Diseases

1.3.3 Mental Illness

1.3.4 Cancer

1.3.5 Others

1.4 Global Drug Repositioning Market Size & Forecast

1.5 Global Drug Repositioning Market Size and Forecast by Region

1.5.1 Global Drug Repositioning Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Drug Repositioning Market Size by Region, (2016-2021)

1.5.3 North America Drug Repositioning Market Size and Prospect (2016-2026)

1.5.4 Europe Drug Repositioning Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Drug Repositioning Market Size and Prospect (2016-2026)

1.5.6 South America Drug Repositioning Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Drug Repositioning Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Drug Repositioning Market Drivers

1.6.2 Drug Repositioning Market Restraints

1.6.3 Drug Repositioning Trends Analysis

2 Company Profiles

2.1 Teva

2.1.1 Teva Details

2.1.2 Teva Major Business

2.1.3 Teva Drug Repositioning Product and Solutions

2.1.4 Teva Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Teva Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Drug Repositioning Product and Solutions

2.2.4 Novartis Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Mylan

2.3.1 Mylan Details

2.3.2 Mylan Major Business

2.3.3 Mylan Drug Repositioning Product and Solutions

2.3.4 Mylan Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Mylan Recent Developments and Future Plans

2.4 Johnson & Johnson

2.4.1 Johnson & Johnson Details

2.4.2 Johnson & Johnson Major Business

2.4.3 Johnson & Johnson Drug Repositioning Product and Solutions

2.4.4 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Johnson & Johnson Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Drug Repositioning Product and Solutions

2.5.4 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 Bausch Health

2.6.1 Bausch Health Details

2.6.2 Bausch Health Major Business

2.6.3 Bausch Health Drug Repositioning Product and Solutions

2.6.4 Bausch Health Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Bausch Health Recent Developments and Future Plans

2.7 GSK

2.7.1 GSK Details

2.7.2 GSK Major Business

2.7.3 GSK Drug Repositioning Product and Solutions

2.7.4 GSK Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 GSK Recent Developments and Future Plans

2.8 ChemRar Group

2.8.1 ChemRar Group Details

2.8.2 ChemRar Group Major Business

2.8.3 ChemRar Group Drug Repositioning Product and Solutions

2.8.4 ChemRar Group Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 ChemRar Group Recent Developments and Future Plans

2.9 Glenmark

2.9.1 Glenmark Details

2.9.2 Glenmark Major Business

2.9.3 Glenmark Drug Repositioning Product and Solutions

2.9.4 Glenmark Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Glenmark Recent Developments and Future Plans

2.10 Fujifilm

2.10.1 Fujifilm Details

2.10.2 Fujifilm Major Business

2.10.3 Fujifilm Drug Repositioning Product and Solutions

2.10.4 Fujifilm Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Fujifilm Recent Developments and Future Plans

2.11 Dr. Reddy

2.11.1 Dr. Reddy Details

2.11.2 Dr. Reddy Major Business

2.11.3 Dr. Reddy Drug Repositioning Product and Solutions

2.11.4 Dr. Reddy Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Dr. Reddy Recent Developments and Future Plans

2.12 R-Pharma

2.12.1 R-Pharma Details

2.12.2 R-Pharma Major Business

2.12.3 R-Pharma Drug Repositioning Product and Solutions

2.12.4 R-Pharma Drug Repositioning Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 R-Pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Drug Repositioning Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Drug Repositioning Players Market Share

3.2.2 Top 10 Drug Repositioning Players Market Share

3.2.3 Market Competition Trend

3.3 Drug Repositioning Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Drug Repositioning Revenue and Market Share by Type (2016-2021)

4.2 Global Drug Repositioning Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Drug Repositioning Revenue Market Share by Application (2016-2021)

5.2 Drug Repositioning Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Drug Repositioning Revenue by Type (2016-2026)

6.2 North America Drug Repositioning Revenue by Application (2016-2026)

6.3 North America Drug Repositioning Market Size by Country

6.3.1 North America Drug Repositioning Revenue by Country (2016-2026)

6.3.2 United States Drug Repositioning Market Size and Forecast (2016-2026)

6.3.3 Canada Drug Repositioning Market Size and Forecast (2016-2026)

6.3.4 Mexico Drug Repositioning Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Drug Repositioning Revenue by Type (2016-2026)

7.2 Europe Drug Repositioning Revenue by Application (2016-2026)

7.3 Europe Drug Repositioning Market Size by Country

7.3.1 Europe Drug Repositioning Revenue by Country (2016-2026)

7.3.2 Germany Drug Repositioning Market Size and Forecast (2016-2026)

7.3.3 France Drug Repositioning Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Drug Repositioning Market Size and Forecast (2016-2026)

7.3.5 Russia Drug Repositioning Market Size and Forecast (2016-2026)

7.3.6 Italy Drug Repositioning Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Drug Repositioning Revenue by Type (2016-2026)

8.2 Asia-Pacific Drug Repositioning Revenue by Application (2016-2026)

8.3 Asia-Pacific Drug Repositioning Market Size by Region

8.3.1 Asia-Pacific Drug Repositioning Revenue by Region (2016-2026)

8.3.2 China Drug Repositioning Market Size and Forecast (2016-2026)

8.3.3 Japan Drug Repositioning Market Size and Forecast (2016-2026)

8.3.4 South Korea Drug Repositioning Market Size and Forecast (2016-2026)

8.3.5 India Drug Repositioning Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Drug Repositioning Market Size and Forecast (2016-2026)

8.3.7 Australia Drug Repositioning Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Drug Repositioning Revenue by Type (2016-2026)

9.2 South America Drug Repositioning Revenue by Application (2016-2026)

9.3 South America Drug Repositioning Market Size by Country

9.3.1 South America Drug Repositioning Revenue by Country (2016-2026)

9.3.2 Brazil Drug Repositioning Market Size and Forecast (2016-2026)

9.3.3 Argentina Drug Repositioning Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Drug Repositioning Revenue by Type (2016-2026)

10.2 Middle East & Africa Drug Repositioning Revenue by Application (2016-2026)

10.3 Middle East & Africa Drug Repositioning Market Size by Country

10.3.1 Middle East & Africa Drug Repositioning Revenue by Country (2016-2026)

10.3.2 Turkey Drug Repositioning Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Drug Repositioning Market Size and Forecast (2016-2026)

10.3.4 UAE Drug Repositioning Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect
3 Hunters Talent Solutions LATAM
Atelerix Life Sciences Inc
David Clark
DSGLOBAL CO.,LTD.
Hitotsubashi University
kovis-group
Saunacore
Suez Consulting
WestRock
Medeon Biodesign
Power Transmission Consulting, PTC AB
Sint Maartenskliniek
ITW Specialty Films
American Fuji Seal, Inc.
Tag-consultants.com
HAZEMAG Systems GmbH
Dabur International
lippert componentrs
Aelea Commodities Private Limited
ERRIA A/S
Chiripal Group
Capstone Partners
VETTEX SRL
Ægir Advisory Services
John Deere
ADTEC Plasma Technology
Cairneagle
Mckinsey
Panasonic Consumer Electronics Company
ACT
Mele & Co
SAZKA a.s.
THIN
Assurance Services International
Intro-act Inc
School of Health Sciences/Democritus University of Thrace
W.L.Gore
Nippon Steel Co.
AFB International
986 Labs
Bamboi
Zaptin Communications LLC
DONGIL MACHINERY
GABALabs
Salon IQ
SW Umwelttechnik Stoiser & Wolschner AG
RSM Dahman Auditors
DentalMonitoring
Emosis Diagnostics
 CDA InterCorp
Lanhe USA, Inc

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005